1.Date of the shareholders' meeting:2026/05/27

2.Important resolutions I.Profit distribution/deficit compensation: Acknowledgment of the 2025 Earnings Distribution.

3.Important resolutions II.Amendments of the company charter: Approved the amendment to the Company's Articles of Incorporation.

4.Important resolutions III.Business report and financial statements: Acknowledgment of the 2025 Business report and financial statements.

5.Important resolutions IV.Election for directors and supervisors: Full Reelection of Directors.

The list of person elected is as below:
Director: Representative of TTY Biopharm Company Limited:Chuan Lin Representative of TTY Biopharm Company Limited:Carl Hsiao Representative of TTY Biopharm Company Limited:Kang-Chi Chou Duei Tsai Representative of TTY Biopharm Company Limited:Yong-Liang Wu
Independent Director: Yaw-Bin Huang;Te-Yu Chou;Shiow-Ming Wu;Yuen-Liang Lai
6.Important resolutions V.Other matters:Approval of proposal on lifting theNon-compete restriction on newly elected directors and their representatives.

7.Any other matters that need to be specified:None.